Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe.

MLA

Lara, Antonieta Medina, et al. “Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe.” PLoS ONE, vol. 7, no. 4, Apr. 2012, pp. 1–10. EBSCOhost, https://doi.org/10.1371/journal.pone.0033672.

APA

Lara, A. M., Kigozi, J., Amurwon, J., Muchabaiwa, L., Wakaholi, B. N., Mujica Mota, R. E., Sarah Walker, A., Kasirye, R., Ssali, F., Reid, A., Grosskurth, H., Babiker, A. G., Kityo, C., Katabira, E., Munderi, P., Mugyenyi, P., Hakim, J., Darbyshire, J., Gibb, D. M., & Gilks, C. F. (2012). Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe. PLoS ONE, 7(4), 1–10. https://doi.org/10.1371/journal.pone.0033672

Chicago

Lara, Antonieta Medina, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E. Mujica Mota, A. Sarah Walker, et al. 2012. “Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe.” PLoS ONE 7 (4): 1–10. doi:10.1371/journal.pone.0033672.